Betaine-homocysteine methyltransferase (BHMT): Genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans

Molecular Genetics and Metabolism

Volumn 71, Issue 3, 2000, Pages 511-519

  Heil, Sandra G ^a   Lievers, Karin J A ^a   Boers, Godfried H ^a   Verhoef, Petra ^b   Den Heijer, Martin ^a   Trijbels, Frans J M ^a   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Betaine; Betaine homocysteine methyltransferase (BHMT); Choline; Homocysteine; Hyperhomocysteinemia; Mutation analysis; Vascular disease

Indexed keywords

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VASCULAR DISEASE;

EID: 0033730997     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.3078     Document Type: Article

References (24)

1. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
2. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
3. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia
4. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
5. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
6. Hyperhomocysteinemia: An independent risk factor for vascular disease
7. Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease
8. Methionine synthase D 919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations
9. Betaine, metabolic by-product or vital methylating agent?
10. Treatment of mild hyperhomocysteinemia
11. Purification, kinetic properties, and cDNA cloning of mammalian betaine-homocysteine methyltransferase
12. Recombinant human liver betaine-homocysteine S-methyltransferase: Identification of three cysteine residues critical for zinc binding
13. Human betaine-homocysteine methyltransferase is a zinc metalloenzyme
14. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene
15. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene
16. The 677C → T mutation in the methylenetetrahydrofolate reductase gene: Associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease
17. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
18. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
19. Three different methods for the determination of total homocysteine in plasma
20. Molecular beacons: Probes that fluoresce upon hybridization
21. Molecular beacons: A new approach for semiautomated mutation analysis
22. Determinants of plasma homocysteine
23. 12 metabolism in families with spina bifida offspring
24. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss